Diversity in medtech: 2022 markedly the best for women in medtech

This year has been one of the most formative for women in medtech leadership roles as representation in the C-suite has reached a new high.

Just 23% of the top executives at the world’s 100 largest medical device companies are women, according to an analysis of Medical Design & Outsourcing‘s annual Big 100 ranking of the top revenue-generating medtech companies.

While that number is up 2 percentage points from 2021, the average composition within the top 100 companies is also up slightly to 22%.

This year has been one of the most formative for women in leadership roles. There were 50 new C-suite appointments. However, 2020 seemingly started the shift in leadership diversity. That year, 37 women moved into C-suite roles in the top 100 companies, followed by 34 new appointments in 2021. Overall, women have moved into 121 new roles in the last three years.

“The fact that the management teams are now tapping into this in 2020 and…

Read more
  • 0

Integra plans to shrink the C-suite after executive’s exit

Glenn Coleman is the former COO of Integra Lifesciences. [Photo courtesy of Integra Lifesciences]

Integra Lifesciences (Nasdaq: IART) will eliminate the position of chief operating officer next week — though the office is already empty.

Former COO Glenn Coleman’s last day at Integra was Friday, according to a separation agreement filed with the Securities and Exchange Commission that same day. Coleman was scheduled to start as the new EVP and CFO at Dentsply Sirona (Nasdaq: XRAY) yesterday.

Princeton, New Jersey-based Integra said in SEC filings that it will eliminate the COO position on Oct. 3 “consistent with the company’s succession planning following its CEO transition in late 2021.”

Integra announced in October 2021 that it hired an outsider as its new CEO, picking former Barco CEO Jan De Witte to succeed Peter Arduini, who left Integra to become president and CEO of GE Heal…

Read more
  • 0

Integra Lifesciences announces new CEO

Incoming Integra LifeSciences CEO Jan D. De Witte [Image courtesy of Integra]Integra LifeSciences (NSDQ:IART) announced today that former Barco CEO Jan D. De Witte will take over the corner office at Integra by the end of the year.

De Witte left Barco effective September 1. He will succeed Peter J. Arduini, who is leaving Integra Lifesciences to lead GE Healthcare.

The top spot at Integra will transition by the end of the year.

Barco’s healthcare portfolio includes a host of medical displays and imaging systems. During his five years at the Kortrijk, Belgium–based company, De Witte led a turnaround that included streamlining the portfolio and strengthening the digital capabilities.

Princeton, N.J.–based Integra has a focus on regenerative tissue technologies and neurosurgical technology.

“The company has a rich history of global leadership in neurosurgery with some of the most recognized brands in plastic and reconstructive surgery…

Read more
  • 0